PE20070846A1 - Compuestos de 1,3-tiazol-4(5h)-ona como inhibidores de yak3 - Google Patents

Compuestos de 1,3-tiazol-4(5h)-ona como inhibidores de yak3

Info

Publication number
PE20070846A1
PE20070846A1 PE2006001364A PE2006001364A PE20070846A1 PE 20070846 A1 PE20070846 A1 PE 20070846A1 PE 2006001364 A PE2006001364 A PE 2006001364A PE 2006001364 A PE2006001364 A PE 2006001364A PE 20070846 A1 PE20070846 A1 PE 20070846A1
Authority
PE
Peru
Prior art keywords
thiazol
amino
yak3
inhibitors
compounds
Prior art date
Application number
PE2006001364A
Other languages
English (en)
Inventor
Kevin J Duffy
Duke M Fitch
Antony N Shaw
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PE20070846A1 publication Critical patent/PE20070846A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I DONDE R ES ARILO, HETEROARILO, ALCOXI, ENTRE OTROS; Q ES (a) , DONDE A, B, D, E Y G FORMAN UN ANILLO QUE CONTIENE 1 A 2 ENLACES DOBLES Y DE 1 A 4 ATOMOS DE NITROGENO, ADEMAS A y B SON C, N Y G, E y D SON CR20, O, S y N; X, Y y Z SON CR20; R20 ES H, HALOGENO, AMINO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: (5Z)-2-[(2,6-DICLOROFENIL)AMINO]-5-(PIRAZOLO[1,5-a]PIRIDIN-5-ILMETILIDENO)-1,3-TIAZOL-4(5H)-ONA; (5Z)-2-[(2,6-DICLOROFENIL)AMINO]-5-(IMIDAZO[1,2-a]PIRIDIN-6-ILMETILIDENO)-1,3-TIAZOL-4(5H)-ONA; ENTRE OTROS. REFERIDA TAMBIEN A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. LOS COMPUESTOS DESCRITOS SON INHIBIDORES DE PROTEINAS YAK3, UTILES EN EL TRATAMIENTO DE ENFERMEDADES DE LOS SISTEMAS ERITROIDE Y HEMATOPOYETICO TALES COMO ANEMIA, ANEMIA APLASTICA, MIELOSUPRESION, CITOPENIA
PE2006001364A 2005-11-08 2006-11-06 Compuestos de 1,3-tiazol-4(5h)-ona como inhibidores de yak3 PE20070846A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73466305P 2005-11-08 2005-11-08

Publications (1)

Publication Number Publication Date
PE20070846A1 true PE20070846A1 (es) 2007-08-12

Family

ID=38024052

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006001364A PE20070846A1 (es) 2005-11-08 2006-11-06 Compuestos de 1,3-tiazol-4(5h)-ona como inhibidores de yak3

Country Status (7)

Country Link
US (1) US20080262027A1 (es)
EP (1) EP1954136A4 (es)
JP (1) JP2009514984A (es)
AR (1) AR057879A1 (es)
PE (1) PE20070846A1 (es)
TW (1) TW200734332A (es)
WO (1) WO2007056683A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007103760A2 (en) * 2006-03-02 2007-09-13 Smithkline Beecham Corporation Thiazolones for use as pi3 kinase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767701B2 (en) * 2002-11-22 2010-08-03 Glaxosmithkline Llc Chemical compounds
US20070249599A1 (en) * 2004-02-25 2007-10-25 Duffy Kevin J Novel Chemical Compounds
WO2007103760A2 (en) * 2006-03-02 2007-09-13 Smithkline Beecham Corporation Thiazolones for use as pi3 kinase inhibitors

Also Published As

Publication number Publication date
EP1954136A2 (en) 2008-08-13
EP1954136A4 (en) 2011-01-05
JP2009514984A (ja) 2009-04-09
WO2007056683A2 (en) 2007-05-18
WO2007056683A3 (en) 2007-11-15
US20080262027A1 (en) 2008-10-23
TW200734332A (en) 2007-09-16
AR057879A1 (es) 2007-12-26

Similar Documents

Publication Publication Date Title
PE20120121A1 (es) Derivados de imidazopirazina como inhibidores de syk
HRP20191665T1 (hr) Sastavi pirolopirola kao aktivatori piruvat kinaze (pkr)
CL2011000512A1 (es) (2r,6s,13as,14ar,16as,z)-n- (ciclopropilsulfonil)-6-(5-metilpirazin-2-carboxamido)-5,16-dioxo-2-(fenantridin-6-iloxi)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahidrociclopropa[e]pirrolo[1,2-a][1,4]diazaciclopentadecin-14a-carboxamida y composicion farmaceutica que lo comprende.
PE20110560A1 (es) NUEVOS DERIVADOS DE TRIAZOLO[4,3-a]PIRIDINA, SU PROCEDIMIENTO DE PREPARACION, SU APLICACION COMO MEDICAMENTOS, COMPOSICIONES FARMACEUTICAS Y NUEVA UTILIZACION PARTICULARMENTE COMO INHIBIDORES DE MET
BRPI0519302A2 (pt) etanossulfonato de sais de 1-(2-metilpropil)-1h-imidazo[4,5-c][1,5]naftiridin-4-amin o e metanossulfonato de 1-(2-metilpropil)-1h-imidazo[4,5-c][1,5]naftiridin-4-amin a, composiÇÕes contendo os mesmos, processos de preparaÇço e uso
RU2009143105A (ru) Производные пирролопиридина и их применение в качестве ингибиторов васе
PE20091712A1 (es) Derivados de azetidina y ciclobutano como inhibidores de jak
PE20120534A1 (es) PIRIMIDINAS FUSIONADAS COMO INHIBIDORES DE Akt
PE20170003A1 (es) Compuestos heterociclicos y usos de los mismos
KR880007535A (ko) 설포닐우레아 화합물
IL271761B (en) (12as)-8-methoxy-9-benzyloxy-11,12,12a,13-tetrahydro-6h-indolo[2,1-c][1,4]benzodiazepine-6-one, 4-benzyloxy-5-methoxy -2-nitrobenzoic acid and a process for their preparation
DE60314623D1 (de) Substituierte pyrazolopyrimidine
CO5631443A2 (es) Derivados de 7-aril-3,9-diazabiciclo (3.3.1) non-6-eno y su uso como inhibidores de renina en el tratamiento de enfermedades de hipertension, cardiovasculares o renales
WO2007083188A3 (en) Improved process for the preparation of an optically active 5h-pyrrolo [3,4-b] pyrazine derivative
PE20080744A1 (es) IMIDAZOL AMINAS COMO INHIBIDORES DE LA ß-SECRETASA
GT200900056A (es) Benzoxazoles y oxazolopiridinas utiles como inhibidores de la quinasa janus
RU2010138648A (ru) Азатрициклические соединения антибиотиков
JP2017510564A5 (es)
AR047466A1 (es) Compuestos derivados de 3h - imidazo[4,5 - b]piridina con actividad inhibidora de quinasa, composiciones farmacéuticas que los contienen como principio activo y su uso en la fabricacion de un medicamento para el tratatmiento de neoplasmas susceptibles.
AR053364A1 (es) Compuesto de 1h-imidazo 84,5-c) piridin -2- ilo, composicion farmaceutica que lo comprende, proceso para prepararla y su uso para preparar un medicamento para tratamiento de cancer o artritis
DE602008003322D1 (de) Pyrrolo (3, 2, 1-ij) chinolin-4-on-derivate zur behandlung von tuberkulose
PE20061351A1 (es) COMPUESTOS 8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA 2,4,8-TRISUSTITUIDOS COMO INHIBIDORES DE LA QUINASA CSBP/RK/p38
TW200738243A (en) Novel process and formulations
PE20070010A1 (es) Penemes triciclicos de 6-alquilideno como inhibidores de beta-lactasas clase d
DE502006004182D1 (de) Substituierte 5,6,7,8-tetrahydro-imidazoä1 ,2-aüpyridin-2-ylamin-verbindungen und deren verwendung zur herstellung von arzneimitteln

Legal Events

Date Code Title Description
FC Refusal